CROI 2015 Program and Abstracts

Poster Listings

836 Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART Initiation Joshua Rhein 1 ; Katherine H. Hullsiek 1 ; Nathan C. Bahr 1 ; Reuben Kiggundu 3 ; Darlisha Williams 3 ; HenryW. Nabeta 3 ; Abdu Musubire 3 ; David B. Meya 3 ; David R. Boulware 1 1 University of Minnesota, Minneapolis, MN, US; 2 University of Minnesota, Minneapolis, MN, US; 3 Makerere University College of Health Sciences, Kampala, Uganda 837 Impact of ART on Mortality in Cryptococcal Meningitis Patients: High- Income Settings Suzanne M. Ingle 1 ; Jose M. Miro 2 ; Hansjakob Furrer 4 ; Amy Justice 5 ; Michael S. Saag 6 ; Christian Manzardo 2 ; Anna Esteve 7 ; Lauren E. Cain 3 ; Jonathan A. Sterne 1 ; MargaretT. May 1 1 University of Bristol, Bristol, United Kingdom; 2 Hospital Clínic–L’Institut D’Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain; 3 Harvard School of Public Health, Boston, MA, US; 4 Bern University Hospital and University of Bern, Bern, Switzerland; 5 Yale University School of Medicine, VA Connecticut Healthcare System, New Haven, CT, US; 6 University of Alabama at Birmingham, Birmingham, AL, US; 7 Centre d’Estudis Epidemiològics Sobre ITS/VIH/SIDA de Catalunya, Barcelona, Spain 838 Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis Joshua Rhein 1 ; Katherine H. Hullsiek 1 ; Bozena Morawski 1 ; Kyle Smith 1 ; Ali Al-Hadab 1 ; Abdu Musubire 2 ; DarlishaWilliams 2 ; Kristen Nielsen 1 ; David B. Meya 2 ; David R. Boulware 1 1 University of Minnesota, Minneapolis, MN, US; 2 Makerere University College of Health Sciences, Kampala, Uganda 2:30 pm– 4:00 pm Syphilis and HIV Coinfection 839 InfectionWith HIV Among Individuals With Primary and Secondary Syphilis: USA, 2013 John R. Su ; Akbar A. Zaidi; Elizabeth A.Torrone; Hillard S.Weinstock US Centers for Disease Control and Prevention, Atlanta, GA, US 840 Risk Factors for Asymptomatic and Symptomatic Neurosyphilis Differ in HIV-Infected Patients With Syphilis Christina Marra ;Trudy Jones; Shelia Dunaway; Emily Ho; Abigail Crooks; LaurenTantalo; Sharon Sahi University of Washington, Seattle, WA, US 841 High Incidence of Syphilis Among Thai MSMWho Started ART Therapy During Acute HIV Infection Donn J. Colby 1 ; Suteeraporn Pinyakorn 1 ; Frits van Griensven 1 ; Eugene Kroon 1 ; Naphassanant Laopraynak 1 ; Robert O’Connell 2 ; Nelson L. Michael 2 ; Praphan Phanuphak 1 ; Jintanat Ananworanich 2 ; Nittaya Phanuphak 1 1 Thai Red Cross AIDS Research Center, Bangkok, Thailand; 2 US Military HIV Research Program, Bethesda, MD, US 842 Serological Response to Treatment of Syphilis in HIV-Positive and HIV- Negative Adults Rulin C. Hechter 1 ; Robyn Neblett Fanfair 2 ;W-L Joanie Chung 1 ; Lauri E. Markowitz 2 ; Sean S. Anand 1 1 Kaiser Permanente Southern California, Pasadena, CA, US; 2 US Centers for Disease Control and Prevention (CDC), Atlanta, GA, US Session P-R7 Poster Session Poster Hall 2:30 pm– 4:00 pm Opportunistic Infections: Odds and End Organs 843 The Exposure and Geospatial Risk Factors for AIDS-Associated Penicilliosis in Vietnam Thuy Le 1 ; Brian Jonat 2 ; NgoT. Cuc 3 ; NguyenT.Thanh 1 ; DangT. Bich 4 ; Cecilia Shikuma 5 ; Jeremy Day 1 ; HeimanWertheim 1 ; Jeremy Farrar 1 ; MarcelWolbers 1 1 Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; 2 New York-Presbyterian University Hospital of Columbia and Cornell, New York City, NY, US; 3 Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam; 4 National Hospital for Tropical Diseases, Hanoi, Viet Nam; 5 Hawaii Center for AIDS, University of Hawaii, Ho Chi Minh, Viet Nam TUESDAY, FEBRUARY 24, 2015 Session P-R6 Poster Session Poster Hall

844 A5265 Clinical Trial: Gentian Violet for Oral Candidiasis is as Effective as Nystatin Pranab K. Mukherjee 1 ; Lauren Patton 2 ; James Hakim 4 ; Huichao Chen 3 ; MaiT. Pho 5 ; Kenneth A. Freedberg 6 ; Caroline Shiboski 7 ; Mahmoud A. Ghannoum 1 ; Robert A. Salata 1 Oral HIV/AIDS Research Alliance (OHARA)/ACTG 1 Case Western Reserve University, Cleveland, OH, US; 2 University of North Carolina, Chapel Hill, NC, US; 3 Harvard School of Public Health, Boston, MA, US; 4 University of Zimbabwe - Parirenyatwa, Harare, Zimbabwe; 5 University of Chicago, Chiago, IL, US; 6 Harvard Medical School, Boston, MA, US; 7 University of California San Francisco (UCSF), San Francisco, CA, US 845 Effective Treatment of Lymphogranuloma Venereum (LGV )W ith 1g Azithromycin AdministeredWeekly for 3Weeks in an HIV-Infected Population José L. Blanco ; Irene Fuertes; Jordi Bosch; Ana Gonzalez; AndreaVergara; Rob Camp; Esteban Martinez;Teresa Estrach; Josep M. Gatell; Merçe Alsina Hospital Clinic, Barcelona, Barcelona, Spain 846 Risk Factors for Staphylococcus Aureus Carriage in HIV-Infected Adults in Southern Botswana Michael J. Reid 1 ; Rebceca Fischer 3 ; Naledi Mannathoko 2 ; Eric Brown 3 ; Andrew Steenhoff 4 1 University of California San Francisco, San Francisco, CA, US; 2 University of Botswana, School of Medicine, Gaborone, Botswana; 3 University of Texas, Texas, Afghanistan; 4 University of Pennsylvania, Gaborone, Botswana 847 Specific Behaviors Predict Staphylococcus aureus Colonization and Skin and Soft Tissue Infections Among HIV-Infected Persons Nancy Crum-Cianflone ; XunWang; AmyWeintrob;Tahaniyat Lalani; Mary Bavaro; Katrin Mende; Michael Ellis; Brian K. Agan Infectious Disease Clinical Research Program, San Diego, CA, US 848 Cytokine Profile in Aqueous Humor of HIV Patients With Ocular Opportunistic Infections Matilde Ruiz-Cruz ; Santiago Avila-Rios; Christopher Ormsby; Claudia Alvarado-de la Barrera;Yuria Ablanedo-Terrazas; Gustavo Reyes-Terán National Institute of Respiratory Diseases, Mexico City, Mexico 849 Effects of H. pylori Co-infection on Immune Parameters in HIV-1 Patients in Ghana Edmund Osei-Kuffour 1 ;Torsten Feldt 1 ; Kirsten A. Eberhardt 2 ; Fred S. Sarfo 4 ; Marieke Soltau 2 ; Jan F. Drexler 3 ; Gerd D. Burchard 2 ; Carsten Münk 1 ; Dieter Häussinger 1 HHECO Study Group 1 University Clinic Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany; 2 Bernhard- Nocht-Institute for Tropical Medicine, Hamburg, Hamburg, Germany; 3 University of Bonn, Bonn, Germany; 4 Kwame Nkrumah University of Science and Technology, Komfo Anokye Teaching Hospital, Kumasi, Ghana 2:30 pm– 4:00 pm Access and Engagement 850 Trends in Healthcare Access and HIV Risk Behaviors—African American Women, 2006-2013 Wade Ivy ; Gabriela Paz-Bailey US Centers for Disease Control and Prevention (CDC), Atlanta, GA, US 851 Engagement in the HIV Care Continuum Among Female Sex Workers in Lilongwe, Malawi Kathryn E. Lancaster 1 ;Thandie Lungu 3 ; Mina C. Hosseinipour 3 ; Katy Chadwick 2 ; Zoe Dibb 2 ; Vivian F. Go 1 ; BrianW. Pence 1 ; Kimberly A. Powers 1 ; Irving F. Hoffman 1 ;William C. Miller 1 1 University of North Carolina, Chapel Hill, NC, US; 2 Theatre for a Change, Lilongwe, Malawi; 3 University of North Carolina Project–Malawi, Lilongwe, Malawi 852 New HIV Cases and ARV Retention in Pretoria: A Gender Project for High- Risk Women Wendee M. Wechsberg 1 ;William A. Zule 1 ; Irene A. Doherty 1 ;Tracy L. Kline 1 ; Jacqueline Ndirangu 1 ; Charles M. van der Horst 2 1 RTI International, Research Triangle Park, NC, US; 2 University of North Carolina, Chapel Hill, NC, US THURSDAY, FEBRUARY 26, 2015 Session P-S1 Poster Session Poster Hall

Poster Listings

65

CROI 2015